New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
08:57 EDTAMAGAMAG Pharmaceuticals price target lowered to $30 from $43 at Summer Street
Summer Street lowered its price target for AMAG Pharmaceuticals to $30 following the company's complete response letter for a broader indication of Feraheme. The firm keeps a Buy rating on the stock.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 28, 2015
07:54 EDTAMAGAMAG Pharmaceuticals management to meet with Maxim
Subscribe for More Information
September 25, 2015
06:24 EDTAMAGLeerink says AMAG 'extremely attractive' after McGuff label disclosure
Subscribe for More Information
06:04 EDTAMAGAMAG obtained package insert for McGuff's Hydroxyprogesterone Caproate
AMAG Pharmaceuticals disclosed last night that following the recent approval by the FDA of the abbreviated new drug application for Hydroxyprogesterone Caproate Injection, initially submitted by McGuff Pharmaceuticals in 2009, the company obtained, through a Freedom of Information Act request, the package insert for the product. Reference Link
September 24, 2015
15:27 EDTAMAGRaymond James expects AMAG Pharmaceuticals shares to rebound sharply
Subscribe for More Information
15:13 EDTAMAGAMAG Pharmaceuticals defended again at Raymond James
12:52 EDTAMAGAMAG Pharmaceuticals selloff unwarranted, says Raymond James
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use